Alan David Waxman MD, Abstract Co-Author: Research Grant, Gamma Medica, Inc

Garrett Li Dejesus MD, Presenter: Nothing to Disclose

1) To understand the unique findings on nuclear renography in patients with hepatorenal syndrome 2)To extrapolate how these findings bolster the leading theory on the pathophysiology of hepatorenal syndrome 3)Review of the indications for performing MAG3 and DTPA scans in patients with comprimsed renal function

A. Introduction      1) Clinical and radiographic importance of this topic B.Objectives      1)What the reader should take away from the presentation C.HRS background      1)What is heptorenal syndrome?           -Clinical/laboratory diagnosis D.Nuclear Renography background      1)What are MAG3 and DTPA scans          -How are they performed          -What general clinical questions can be answered with these scans          -Why are these scans helpful in hepatorenal syndrome D.Case Review      1) Clinical cases with accompanying charts demonstrating the characteristic findings of hepatorenal syndrome on MAG3 and DTPA scans E.Summary and Key points     1)Review basics of MAG3 and DTPA scans     2)Review characteristic findings seen in hepatorenal syndrome     3)Explain how these findings support the leading theory behind the mechanism of hepatorenal syndrome. F.References

http://abstract.rsna.org/uploads/2014/14011614/14011614_2n8g.pdf

Waxman, A, Dejesus, G, Hepatorenal Syndrome in Nuclear Renography: Characteristic Findings on MAG3 and DTPA Scans.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14011614.html